Recombinant Human USP18 Protein ，His & Myc

USP18 (Ubiquitin-specific protease 18) is an essential deubiquitinating enzyme that plays a crucial role in various cellular processes, including the regulation of the immune response, cell differentiation, and development. It is known for its ability to reverse ubiquitination, a post-translational modification that typically targets proteins for degradation, thus influencing protein stability and function. USP18 is particularly important in the context of type I interferon signaling, as it modulates the antiviral response by deubiquitinating pathway components and preventing excessive inflammatory responses. Dysregulation of USP18 has been implicated in several diseases, including autoimmune disorders and cancer, highlighting its potential as a therapeutic target. The study of recombinant USP18 proteins aims to elucidate its enzymatic mechanisms, structural properties, and interactions with substrates. This research could provide insights into its role in disease pathology and aid in the development of novel therapeutic strategies aimed at modulating USP18 activity for clinical benefit. Understanding USP18 function at the molecular level also contributes to the broader field of ubiquitin biology and helps clarify the complex regulatory networks that govern cellular homeostasis. As such, the production and characterization of recombinant USP18 proteins are crucial for advancing our understanding of its multifaceted roles in health and disease.